Filing Details
- Accession Number:
- 0001209191-19-020454
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-19 18:42:41
- Reporting Period:
- 2019-03-18
- Accepted Time:
- 2019-03-19 18:42:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1649167 | Frederic Pla | 301 Penobscot Dr. Redwood City CA 94063 | Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-03-18 | 1,000 | $27.48 | 32,575 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-03-18 | 1,000 | $75.12 | 31,575 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-03-19 | 1,800 | $27.48 | 33,375 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-03-19 | 1,400 | $27.00 | 34,775 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-03-19 | 1,500 | $31.98 | 36,275 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-03-19 | 4,700 | $75.00 | 31,575 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) Holding | Disposition | 2019-03-18 | 1,000 | $0.00 | 1,000 | $27.48 |
Common Stock | Employee Stock Option (right to buy) Holding | Disposition | 2019-03-19 | 1,800 | $0.00 | 1,800 | $27.48 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-03-19 | 1,500 | $0.00 | 1,500 | $31.98 |
Common Stock | Employee Stock Option (right to buy) Holding | Disposition | 2019-03-19 | 1,400 | $0.00 | 1,400 | $27.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
45,453 | 2027-01-31 | No | 4 | M | Direct | |
43,653 | 2027-01-31 | No | 4 | M | Direct | |
77,167 | 2025-01-01 | No | 4 | M | Direct | |
17,767 | 2026-02-16 | No | 4 | M | Direct |
Footnotes
- Includes an aggregate of 13,381 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $75.11 to $75.13.
- Represents actual sale price.
- The option became exercisable as to 25% of the shares on January 31, 2018, and becomes exercisable as to 1/48th of the shares each full month thereafter.
- The option became exercisable as to 25% of the shares on January 1, 2016, and became exercisable as to 1/48th of the shares each full month thereafter.
- The option became exercisable as to 25% of the shares on February 16, 2017, and became exercisable as to 1/48th of the shares each full month thereafter.